Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 36.88
(4.06%)
CNY 36.88
(4.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 893.84 Million CNY | -8.33% |
| 2022 | 974.5 Million CNY | 10.79% |
| 2021 | 879.62 Million CNY | 7.67% |
| 2020 | 816.93 Million CNY | -4.44% |
| 2019 | 854.9 Million CNY | 25.46% |
| 2018 | 681.4 Million CNY | 68.21% |
| 2017 | 405.09 Million CNY | 50.86% |
| 2016 | 268.52 Million CNY | 102.28% |
| 2015 | 132.75 Million CNY | 27.82% |
| 2014 | 103.85 Million CNY | 50.79% |
| 2013 | 68.87 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 251.43 Million CNY | 23.56% |
| 2024 Q2 | 253.59 Million CNY | 0.86% |
| 2024 Q3 | 286.09 Million CNY | 12.82% |
| 2023 Q4 | 203.5 Million CNY | -13.1% |
| 2023 FY | 893.36 Million CNY | -8.33% |
| 2023 Q3 | 234.17 Million CNY | 2.64% |
| 2023 Q2 | 228.15 Million CNY | 0.28% |
| 2023 Q1 | 227.52 Million CNY | 4.63% |
| 2022 Q2 | 261.83 Million CNY | 17.28% |
| 2022 Q1 | 223.25 Million CNY | 8.75% |
| 2022 FY | 974.5 Million CNY | 10.79% |
| 2022 Q4 | 217.45 Million CNY | -20.04% |
| 2022 Q3 | 271.96 Million CNY | 3.87% |
| 2021 Q2 | 243.16 Million CNY | 24.19% |
| 2021 Q1 | 195.8 Million CNY | -10.38% |
| 2021 FY | 879.62 Million CNY | 7.67% |
| 2021 Q3 | 235.36 Million CNY | -3.21% |
| 2021 Q4 | 205.29 Million CNY | -12.78% |
| 2020 FY | 816.93 Million CNY | -4.44% |
| 2020 Q1 | 154.83 Million CNY | -36.36% |
| 2020 Q2 | 209.75 Million CNY | 35.47% |
| 2020 Q3 | 212.28 Million CNY | 1.21% |
| 2020 Q4 | 218.48 Million CNY | 2.92% |
| 2019 Q3 | 182.47 Million CNY | -16.41% |
| 2019 Q2 | 218.3 Million CNY | 16.68% |
| 2019 Q1 | 187.09 Million CNY | 0.0% |
| 2019 FY | 854.9 Million CNY | 25.46% |
| 2019 Q4 | 243.28 Million CNY | 33.33% |
| 2018 FY | 681.4 Million CNY | 68.21% |
| 2017 FY | 405.09 Million CNY | 50.86% |
| 2016 FY | 268.52 Million CNY | 102.28% |
| 2016 Q1 | 42.88 Million CNY | 8.04% |
| 2016 Q2 | 42.88 Million CNY | 0.0% |
| 2015 Q2 | 28.29 Million CNY | 0.0% |
| 2015 Q1 | 28.29 Million CNY | 0.0% |
| 2015 Q4 | 39.68 Million CNY | 0.0% |
| 2015 FY | 132.75 Million CNY | 27.82% |
| 2014 FY | 103.85 Million CNY | 50.79% |
| 2013 FY | 68.87 Million CNY | 0.0% |